However, Han et al demonstrated that miR‐106a accelerated cell migration and EMT process in lung adenocarcinoma through targeting TP53INP1, suggesting that miR‐106a exacerbated bone metastasis in lung cancer.21 Here, TP53INP1 is linked to lung cancer.